Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Edwards

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicityJ S Kong, L J Peters, J T Wharton, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literatureS Piamsomboon, A P Kudelka, W Termrungruanglert, et al.
Cancer|December 15, 1985
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamideD M Gershenson, L J Copeland, J J Kavanagh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Anti-Cancer Drugs|June 1, 1996
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, C F Verschraegen, T Levy, et al.
Annals of Internal Medicine|February 26, 2000
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancerS Vadhan-Raj, C F Verschraegen, C Bueso-Ramos, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinomaA P Kudelka, A Hasenburg, C F Verschraegen, et al.
Anti-Cancer Drugs|August 1, 1997
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinomaA P Kudelka, Z H Siddik, D Tresukosol, et al.
Anti-Cancer Drugs|June 23, 1999
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerC F Verschraegen, E Gupta, E Loyer, et al.
Anti-Cancer Drugs|September 1, 1996
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literatureS Piamsomboon, W Termrungruanglert, A P Kudelka, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicityJ S Kong, L J Peters, J T Wharton, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literatureS Piamsomboon, A P Kudelka, W Termrungruanglert, et al.
Cancer|December 15, 1985
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamideD M Gershenson, L J Copeland, J J Kavanagh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Anti-Cancer Drugs|June 1, 1996
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, C F Verschraegen, T Levy, et al.
Annals of Internal Medicine|February 26, 2000
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancerS Vadhan-Raj, C F Verschraegen, C Bueso-Ramos, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinomaA P Kudelka, A Hasenburg, C F Verschraegen, et al.
Anti-Cancer Drugs|August 1, 1997
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinomaA P Kudelka, Z H Siddik, D Tresukosol, et al.
Anti-Cancer Drugs|June 23, 1999
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerC F Verschraegen, E Gupta, E Loyer, et al.
Anti-Cancer Drugs|September 1, 1996
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literatureS Piamsomboon, W Termrungruanglert, A P Kudelka, et al.
Pageof 16